Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P McGuire

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Investigational New Drugs|January 1, 1986
A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)W P McGuire, J A Blessing, K Hatch, et al.
Investigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, J S Berek, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Methodology phase II clinical trial in cancerF M Muggia, M Rozencweig, M J Staquet, et al.
American Journal of Clinical Oncology|August 26, 1998
A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group StudyR Asbury, J A Blessing, G C Reid, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1984
A specific HPLC assay to determine the pharmacokinetics of methotrexate in patientsM L Chen, W P McGuire, T E Lad, et al.
Investigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, K D Hatch, et al.
Investigational New Drugs|January 1, 1986
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyW P McGuire, J A Blessing, P J DiSaia, et al.
The American Journal of the Medical Sciences|January 19, 1999
Pancreatic polypeptide hypersecretion associated with a neuroendocrine carcinoma of the gallbladderN N Marrano, L S Blevins, A A Gal, et al.
The Journal of Allergy and Clinical Immunology|October 11, 1992
Anaphylaxis to carboplatin--a new platinum chemotherapeutic agentH H Windom, W P McGuire, R G Hamilton, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|February 1, 1984
Preirradiation chemotherapy for advanced head and neck carcinomasL J Kukla, R V Mantravadi, E L Applebaum, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Investigational New Drugs|January 1, 1986
A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)W P McGuire, J A Blessing, K Hatch, et al.
Investigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, J S Berek, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Methodology phase II clinical trial in cancerF M Muggia, M Rozencweig, M J Staquet, et al.
American Journal of Clinical Oncology|August 26, 1998
A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group StudyR Asbury, J A Blessing, G C Reid, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1984
A specific HPLC assay to determine the pharmacokinetics of methotrexate in patientsM L Chen, W P McGuire, T E Lad, et al.
Investigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, K D Hatch, et al.
Investigational New Drugs|January 1, 1986
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyW P McGuire, J A Blessing, P J DiSaia, et al.
The American Journal of the Medical Sciences|January 19, 1999
Pancreatic polypeptide hypersecretion associated with a neuroendocrine carcinoma of the gallbladderN N Marrano, L S Blevins, A A Gal, et al.
The Journal of Allergy and Clinical Immunology|October 11, 1992
Anaphylaxis to carboplatin--a new platinum chemotherapeutic agentH H Windom, W P McGuire, R G Hamilton, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|February 1, 1984
Preirradiation chemotherapy for advanced head and neck carcinomasL J Kukla, R V Mantravadi, E L Applebaum, et al.
Pageof 12